WBB Securities Revenue and Competitors
Estimated Revenue & Valuation
- WBB Securities's estimated annual revenue is currently $2.5M per year.
- WBB Securities's estimated revenue per employee is $144,529
Employee Data
- WBB Securities has 17 Employees.
- WBB Securities grew their employee count by -19% last year.
WBB Securities's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Compliance Officer | Reveal Email/Phone |
2 | President/Managing Partner | Reveal Email/Phone |
3 | Financial Advisor | Reveal Email/Phone |
WBB Securities Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $163.9M | 575 | 3% | N/A | N/A |
What Is WBB Securities?
Headquartered in San Diego, CA and Clark, NJ, WBB Securities, LLC is a full-service, independent broker/dealer and registered investment adviser that is known for its insightful Investment Research & Banking covering biomedical, medical device, and life science firms. WBB's focus is to provide independent financial advisors with the tools and support necessary to serve their clients in a dynamic business environment. WBB has branches throughout the United States.. Founded in 2001, WBB remains privately-held to ensure that we continue to provide independent financial advisors with solutions-oriented, full-service operations, compliance, insurance support and the private-client experience in a low-cost platform. We serve ethical, entrepreneurial-minded financial advisors with the tools and expertise necessary to serve their clients and thrive in an increasingly challenging marketplace. Our investment banking division specializes in financial advisory M&A services covering biotechnology, medical device, and life science firms. Our head banker, Steve Brozak, is regularly quoted and published in a variety of media, including ABC News, Bloomberg, and Forbes. Our research has garnered accolades from the Financial Times/Starmine ranking system (Pharmaceuticals in 2013). The Wall Street Journal's "Best of the Street" survey 2011 (Medical Equipment & Supplies), and the Financial Times/Starmine ranking system (Biotechnology in 2010). Member FINRA/SIPC, a Registered Investment Adviser
keywords:N/AN/A
Total Funding
17
Number of Employees
$2.5M
Revenue (est)
-19%
Employee Growth %
N/A
Valuation
N/A
Accelerator
WBB Securities News
WBB Securities raised shares of Paratek Pharmaceuticals from a buy rating to a strong-buy rating and set a $11.00 target price on the...
... Director and Head of Healthcare Equity Research at Wedbush Securities. ... is the Managing Partner and President of WBB Securities, LLC.
Steve Brozak - WBB Securities. Kumar Raja - Brookline Capital Markets. Operator. Greetings, and welcome to the SCYNEXIS, Inc. Fourth Quarter...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.4M | 17 | -11% | N/A |
#2 | $0.8M | 17 | 6% | $21.4M |
#3 | $3.6M | 17 | N/A | N/A |
#4 | $1.5M | 17 | N/A | N/A |
#5 | $1.5M | 17 | N/A | N/A |